TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator.
about
The emerging insights into catalytic or non-catalytic roles of TET proteins in tumors and neural developmentMultiple Functions of Ten-eleven Translocation 1 during TumorigenesisHypoxia, Epithelial-Mesenchymal Transition, and TET-Mediated Epigenetic ChangesCommon stemness regulators of embryonic and cancer stem cellsG9A performs important roles in the progression of breast cancer through upregulating its targets.Epigenetic regulation of epithelial-mesenchymal transitionConnecting the dots: chromatin and alternative splicing in EMT.Epigenetics, TET proteins, and hypoxia in epithelial-mesenchymal transition and tumorigenesisTen-eleven translocation 1 (TET1) methylation is associated with childhood asthma and traffic-related air pollution.Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.Increased TET1 Expression in Inflammatory Microenvironment of Hyperinsulinemia Enhances the Response of Endometrial Cancer to Estrogen by Epigenetic Modulation of GPER.Hypoxia-induced TET1 facilitates trophoblast cell migration and invasion through HIF1α signaling pathway.TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer.Exercise and the Skeletal Muscle Epigenome.A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer.Differential expression of ten-eleven translocation genes in endometrial cancers.Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.Probable Chemical Hypoxia Effects on Progress of CNV Through Induction of Promoter CpG Demethylation and Overexpression of IL17RC in Human RPE Cells.The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system.Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors.The EMT spectrum and therapeutic opportunities.Association of TET1 expression with colorectal cancer progression.Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation.High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancerTet1 facilitates hypoxia tolerance by stabilizing the HIF-α proteins independent of its methylcytosine dioxygenase activity.Limitations of oxygen delivery to cells in culture: An underappreciated problem in basic and translational research.Salinomycin kills cancer stem cells by sequestering iron in lysosomes.Selective inhibition of CTCF binding by iAs directs TET-mediated reprogramming of 5-hydroxymethylation patterns in iAs-transformed cells.Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-α protein stability and activity.Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer
P2860
Q26739014-425F31E2-2B4C-484A-9E42-165EA8DC368CQ26740522-E8D24FC7-1C28-45C5-A6F3-EA28A0B576BDQ26767183-316ABFE4-453B-400D-8B41-E1600F78A9C7Q26777882-623DB996-ED39-4803-8270-62BC3B13F604Q33751161-1317A657-EDC7-42E6-9297-3A430B10FDA4Q33764436-799AF173-CDB4-4370-A707-D2A1FF581AC1Q36441240-B078066C-121B-4821-BFA0-C9C76BA1EBDDQ36573115-41123FA3-2C0D-448C-907F-7A93DB7EF0CAQ36665038-66B45D7C-A5D3-4592-89BC-9F82C94391C8Q37702224-4080DC13-F86C-4801-BDE1-E3E19F52211AQ37738104-A1A09EB8-BBB8-4DB5-82BD-83335EABDAE9Q38624925-66DF7C3A-3D1B-4CFC-B1DC-91BA4B436E53Q38718420-B88952E0-D203-44E0-952D-DA7650958924Q38742668-BDDA6387-1D5F-4344-8327-0DEC02A6EA88Q38771093-312D4276-8271-4616-A3A5-168D445FB8E4Q38871612-A3F189EB-EE82-46B5-B29F-9E791C6AA130Q38909048-5D215D24-6D12-4407-B611-8FA3787B2306Q38924650-C9C4FC84-4FBD-415C-ACFE-3F0E380CFE97Q39195350-05670492-29BE-49E1-B855-4DE2FC7ACB5FQ39205930-01F9F66B-2A8B-4DD8-AB2E-7557BB3A5893Q39329818-D2507866-938C-4FDF-AF93-8E3F8F7606F3Q40474680-FC2FA06A-2FE1-49B6-9DE0-A8EFA87F88BDQ42077485-A65D808B-2A77-40DD-A341-78A59006BDF4Q42539779-EA3F1AAC-8A1D-401D-AF91-8E8EF29494FFQ46284307-699AF873-A3AC-4D0C-93C2-E415783F5A3AQ46285536-C5FD4F6E-CEAA-4365-9E09-1C5636697EBCQ46302821-F2B4CD18-C9DD-4C22-A861-F9EDA5993F91Q47116981-0A56DB3E-A168-44DA-B31C-98470A0E3FABQ47651765-B9498395-329D-41BE-A708-D4B781B7E9F2Q55280441-8AD2165E-9F1F-46D4-9139-89A56C3DE433Q58797571-230F9F80-9B20-40F5-9890-D2FBDB6C68F0
P2860
TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
TET1 regulates hypoxia-induced ...... n by acting as a co-activator.
@ast
TET1 regulates hypoxia-induced ...... n by acting as a co-activator.
@en
TET1 regulates hypoxia-induced ...... n by acting as a co-activator.
@nl
type
label
TET1 regulates hypoxia-induced ...... n by acting as a co-activator.
@ast
TET1 regulates hypoxia-induced ...... n by acting as a co-activator.
@en
TET1 regulates hypoxia-induced ...... n by acting as a co-activator.
@nl
prefLabel
TET1 regulates hypoxia-induced ...... n by acting as a co-activator.
@ast
TET1 regulates hypoxia-induced ...... n by acting as a co-activator.
@en
TET1 regulates hypoxia-induced ...... n by acting as a co-activator.
@nl
P2093
P2860
P1433
P1476
TET1 regulates hypoxia-induced ...... n by acting as a co-activator.
@en
P2093
Hsei-Wei Wang
Hsiao-Fan Chen
Kou-Juey Wu
Shu-Chun Teng
Sung-Yuan Chen
Wei-Chung Cheng
Ya-Ping Tsai
Zih-Jie Shen
P2860
P2888
P356
10.1186/S13059-014-0513-0
P577
2014-12-03T00:00:00Z
P5875
P6179
1046866760